Effect of metformin on progression-free survival outcomes in patients with advanced or metastatic HR+, HER2– breast cancer: subgroup analysis of STEPAUT. (March 2017) - Egle, D.; Marth, C.; Steger, G.; Bartsch, R.; Pfeiler, G.; Greil, R.; Helfgott, R.; Öhler, L.; Hennebelle, M.; Gnant, M.